Next, we explored MFAP2 expression in various types of glioma and observed that MFAP2 expression levels correlated positively with tumor grade, histology, recurrence, and other biomarkers such as 1p19q codeletion, IDH status, TERT expression, ATRX status, and chromosomes 7 and 10. Here, MFAP2 is linked to central nervous system cancer.